In this study, PD‐L1 expression in the whole tumour area, comprising tumour cells, the stroma and immune cells, was correlated with its expression in melanoma cells, suggesting that tumour cells are key contributors to the activation of the PD‐1/PD‐L1 immunoinhibitory axis. The gene discussed is CD274; the disease is melanoma.